Approvals of COVID-19 biologics will put huge pressure on large scale bioprocessing networks, according to CPhI Annual Report.

The third part of the 2020 CPhI Annual Report released during the second week of the CPhI Festival of Pharma predicts, that if approved, COVID vaccines...

After Sputnik V, Russia grants approval to 2nd COVID-19 vaccine EpiVacCorona.

Russia announced that it has granted regulatory approval to another Covid-19 vaccine named EpiVacCorona. This comes after the country granted similar approval to Sputnik V, making it the first..

New Zealand signs deal with Pfizer, BioNTech for Covid-19 vaccine.

The New Zealand government signed a deal on Monday to buy 1.5 million COVID-19 vaccines from Pfizer Inc and Germany's BioNTech, with delivery potentially as early as the first quarter of 2021.....

UK joins global trial to test BCG vaccine against COVID-19.

A global trial, designed to test the theory that the BCG vaccine could help protect against COVID-19, will soon start recruitment in the UK. Led by the Murdoch Children's Research Institute in Melbourne...

FUJIFILM Diosynth Biotechnologies Stands Ready to Manufacture Lilly COVID-19 Antibody for Low- and Middle-Income Countries.

FUJIFILM viral vaccines and viral vectors, announced that it will manufacture Eli Lilly and Company's COVID-19 therapeutic antibody at its GMP facility...

Pfizer Gets FDA OK to Test Adolescents in COVID-19 Vaccine Trial.

To date, all the major clinical trials of vaccines against COVID-19 have been in adults. Typically, Phase I safety trials were in healthy volunteers ages 18 to 55. Phase II and Phase III trials expanded that to include people...

Astrazeneca Says Covid-19 Long-Acting Antibody Combination AZD7442 Rapidly Advances Into Phase III Clinical Trials.

AstraZeneca's long-acting antibody combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at sites..

Thermo Fisher Scientific Further Expands COVID-19 Test Portfolio with Two New Antibody Tests.

Thermo Fisher Scientific introduced two new SARS-CoV-2 antibody tests: the Thermo Scientific OmniPATH COVID-19 Total Antibody ELISA test...

Merck's New VirusExpress Platform Speeds Development of Cell and Gene Therapies.

Merck, a leading science and technology company, has bolstered its viral vector manufacturing capabilities with the launch of its VirusExpress Lentiviral Production.

Roche to launch laboratory SARS-CoV-2 antigen test to support high-volume testing of suspected COVID-19 patients.

Roche announced that it intends to launch a high-volume SARS-CoV-2 Antigen test as an aid in the diagnosis of Severe Acute Respiratory Syndrome..

Direct Biologics Granted Expanded Access by FDA for ExoFlo in the Treatment of COVID-19.

Direct Biologics announced that the FDA has granted expanded access for ExoFlo in the treatment of patients with COVID-19 ARDS...

Sharp invests $10M in biologics and injectables packaging equipment.

Sharp has announced a further investment of $10M in equipment capabilities to directly support client demand in the biologics and injectables market...